-
Recent Posts
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
- ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: FDA
Developing Partnerships with Patients: Salina Prasad and Steve Morin of the FDA
With increasing attention toward patient-centric drug development, patients play an integral and growing role in the development of therapeutic products. Patient organizations are engaging in basic disease research, working with medical product developers and providing meaningful input to regulators. Through … Continue reading
Posted in Uncategorized
Tagged FDA, food and drug administration fda, Salina Prasad, Steve L Morin
Dr. Jerry Silver, PhD. – Presents Research Updates from 2011 Nerve Bridging Project at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Jerry Silver, PhD. Professor, Department of Neurosciences, Case Western Reserve University “Functional Regeneration Into and Well Beyond the Glial Scar” Dr. … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Neuroscience Abstracts, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, Case Western Reserve University, Ch'ase, Chondroitinase ABC, chronic spinal cord injury, clinical trials, clinical trials spinal cord injury, corticospinal tract, CSPG scar degradation, Dr. Jerry Silver, FDA, LAR, locomotion, nerve bridging, neurite growth, NIH, paralysis, peptide, proteoglycans, spinal cord injury research, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Hans Keirstead, PhD – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Hans Keirstead, PhD. Professor of Anatomy & Neurobiology, Professor of Neurological Surgery, RIRC “Stem-Cell Based Approaches to Treat Spinal Cord Injury” … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged advocacy, astrocytes, axon regeneration, California Stem Cells, chronic spinal cord injury, CIRM, clinical trials, embryonic stem cells, FDA, Geron, IPS cells, lenti virus, locomotion, motor function, motor neuron, mTOR pathway, neurite growth, neurite outgrowth, NIH, PTEN, RIRC, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Mark Tuszynski, MD, PhD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Mark Tuszynski, MD, PhD Professor of Neurosciences, Director of the Center for Neural Repair, UC San Diego “Neural Stem Cells for … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, axons, B-tublin, CAP-23, Chondroitinase ABC, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, corticospinal tract, Dr. Mark Tuszynski, embryonic stem cells, ephrin, FDA, GAP-43, growth factors, MAG, myelin, netrin, NeuralStem cells (566RSC-UBQT), neurotrophic support, NIH, Nogo, paralysis, peripheral nerves, proteoglycans, PTEN, regeneration, research, semaphorin, SOCS3, spinal cord injury research, stem cell biology, stem cells, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Aileen Anderson, PhD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson, PhD. Associate Professor, Reeve-Irvine Research Center “Stem Cell Strategies for Spinal Cord Injury: Managing the Microenvironment” Dr. Anderson investigates … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged axon regeneration, axons, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, Dr. Aileen Anderson, FDA, locomotion, motor function, neurite growth, NIH, paralysis, regeneration, RIRC, stem cell biology, Stem Cells Inc, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Stephen Huhn, MD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Stephen Huhn, MD, FACS, FAAP, Vice President, Head of the CNS Program, Stem Cells, Inc. “Phase I/II Study of Human Neural … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, Dr. Stephen Huhn, embryonic stem cells, FDA, regeneration, spinal cord injury research, Stem Cells Inc, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Translation of Stem Cell Based Therapies
Hans Keirstead, PhD Professor of Anatomy & Neurobiology, Neurological Surgery, University of California at Irvine Reeve-Irvine Research Center Additional Information:
Posted in Advocacy, Chronic Spinal Cord Injury Research, Gene Therapy, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, California Stem Cells, chronic spinal cord injury, Dr. Hans Keirstead, embryonic stem cells, FDA, locomotion, motor function, neurite growth, NIH, paralysis, RIRC, stem cells
Statement Regarding Potential Budget Cuts to the FDA and NIH: Unite 2 Fight Paralysis is the Voice of the Cure
The Alliance for Regenerative Medicine (ARM), the advocacy voice for regenerative medicine, has significant concerns about the automatic budget cuts to the US Food and Drug Administration (FDA) and National Institutes of Health (NIH) scheduled to take affect on January … Continue reading
Spinal Cord Injury—Innovation Measured in Decades, Not Headlines
This blog column is about how short-sighted we have become about medical innovation–where it comes from, when it becomes noteworthy and the reality that headlines drive our perception rather than the long, hard work of discovery. Understandably, the column has … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research
Tagged FDA, funding, NIH, research, spinal cord injury
